Ocular Therapeutix, Inc. (OCUL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.27B |
| Enterprise Value | 1.62B |
| P/E Ratio | -4.6 |
| PEG Ratio | 2.98 |
| Price/Sales Ratio | 29.27 |
| Price/Book Ratio | 3.43 |
| Enterprise/Revenue | 20.32 |
| Enterprise/EBITDA | -3.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -6.49 |
| Operating Margin | -6.81 |
| Return On Assets | -0.54 |
| Return On Equity | -0.6 |
| Revenue | 51.82M |
| Revenue/Share | 0.22 |
| Gross Profit | 45.25M |
| EBITDA | -249.78M |
| Net Income | -265.94M |
| Diluted EPS | -1.42 |
| Total Cash | 530.61M |
| Total Cash/Share | 2.35 |
| Total Debt | 80.01M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 9.12 |
| Book Value Per Share | 1.96 |
| 52-Week Change | -38 |
| 52-Week High | 16.44 |
| 52-Week Low | 6 |
| Moving Average 50 Days | 8.4 |
| Moving Average 200 Days | 9 |
| Average Volume | 3.09M |
| Shares Outstanding | 219.62M |
| % Held by Institutions | 93.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |